ONCT
2024-09-30 | ||||
---|---|---|---|---|
Revenues, total | 494 | |||
Research and development expense (excluding acquired in process cost) | 6,448 | |||
General and administrative expense, total | 2,727 | |||
Operating expenses | 9,175 | |||
Operating income (loss) | -8,681 | |||
Investment income, interest | 217 | |||
Net loss | -8,464 | |||
Unrealized gain (loss) on available-for-sale securities, net | 4 | |||
Comprehensive income (loss), net of tax, attributable to parent | -8,460 | |||
Basic eps | -2.86 | |||
Diluted eps | -2.86 | |||
Basic average shares | 2,960,000 | |||
Diluted average shares | 2,960,000 |